OmniVision Vice President of Process Engineering Dr. Howard E. Rhodes to Present at 2009 International Image Sensor Workshop

Date : 06/24/2009 @ 4:38PM
Source : PR Newswire
Stock : Omnivision Technologies (MM) (OVTI)
Quote : 15.29  -0.41 (-2.61%) @ 3:50PM
<< BackQuote Chart Financials

 

OmniVision Vice President of Process Engineering Dr. Howard E. Rhodes to Present at 2009 International Image Sensor Workshop

SANTA CLARA, Calif., June 24 /PRNewswire-FirstCall/ --

OmniVision Technologies, Inc. (NASDAQ:OVTI), a leading developer of advanced digital imaging solutions, today announced that its vice president of Process Engineering, Dr. Howard E. Rhodes, will present "The Mass Production of BSI Image Sensors: Performance Results" at the International Image Sensor Workshop in Bergen, Norway on Thursday, June 25, 2009 at 4:00 p.m. local time.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090624/SF37813)

Rhodes holds 149 patents and has published over 15 technical papers. Since joining OmniVision, he has filed for 18 patents. In June 2005, Rhodes received the Walter Kosonocky Award for his published work in CMOS Imaging.

OmniVision introduced the industry's first commercial availability of CMOS devices based on backside illumination technology in May 2008. OmniBSI(TM) delivers a number of performance improvements over front-side illumination technology, including increased sensitivity per unit area, improved quantum efficiency, reduced cross talk and photo response non-uniformity, which all lead to significant improvements in image quality.

About OmniVision

OmniVision Technologies (NASDAQ:OVTI) is a leading developer of advanced digital imaging solutions. Its award-winning CMOS imaging technology enables superior image quality in many of today's consumer and commercial applications, including mobile phones, notebook and webcams, digital still and video cameras, security and surveillance, automotive and medical imaging systems. Find out more at http://www.ovt.com/

Safe-Harbor Language

Certain statements in this press release, including statements regarding the expected benefits, performance and capabilities of, of OmniBSI technology are forward-looking statements that are subject to risks and uncertainties. These risks and uncertainties, which could cause the forward-looking statements and OmniVision's results to differ materially, include, without limitation: potential errors, design flaws or other problems with OmniBSI, customer acceptance, demand, and other risks detailed from time to time in OmniVision's Securities and Exchange Commission filings and reports, including, but not limited to, OmniVision's annual report filed on Form 10-K and quarterly reports filed on Form 10-Q. OmniVision expressly disclaims any obligation to update information contained in any forward-looking statement.

OmniVision(R), OmniPixel(R) and TrueFocus(R) are registered trademarks of OmniVision Technologies, Inc. The OmniVision logo, CameraCube(TM), OmniBSI(TM), OmniPixel2(TM), OmniPixel3(TM), OmniPixel3-HS(TM) and SquareGA(TM) are trademarks of OmniVision Technologies, Inc. All other trademarks are the property of their respective owners.

http://www.newscom.com/cgi-bin/prnh/20090624/SF37813

DATASOURCE: OmniVision Technologies, Inc.

CONTACT: Media, Martijn Pierik of Impress Public Relations,

+1-602-366-5599, , for OmniVision Technologies; Company,

Tamara Snowden, +1-408-653-3184, , or Investors, Chesha

Gibbons, +1-408-653-3263, , both of OmniVision Technologies

Web Site: http://www.ovt.com/


Omnivision Technologies (MM) Historical Chart Omnivision Technologies (MM) Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
The Spread Bet Centre :: The CFD Centre :: Financial Glossary :: Forex Rates, Charts & News
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright 1999-2010 ADVFN PLC. Copyright Notice & Privacy Policy :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
34 site:2us 100321 15:30